Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine if a reduction in the enzyme 1-hydroxylase, which activates Vitamin D, is the cause of overactivity of the parathyroid glands (called secondary hyperparathyro...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of Maryland, Baltimore
NCT03633708 · Secondary Hyperparathyroidism, Chronic Kidney Disease
NCT04922892 · Secondary Hyperparathyroidism;Parathyroidectomy
NCT06434961 · Secondary Hyperparathyroidism
NCT04064827 · Chronic Kidney Disease (CKD), Secondary Hyperparathyroidism (SHPT)
NCT02859896 · Secondary Hyperparathyroidism-Chronic Kidney Disease
University of Maryland School of Medicine Division of Endocrinology
Baltimore, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions